← FDA DRUG APPROVALS

FDA ANDA · ANDA062888

PRINCIPEN

Sponsor: APOTHECON

APPLICATION
ANDA062888
TYPE
ANDA
ORIGINAL APPROVAL
1988-03-04
LATEST ACTION
1988-03-04
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

PRINCIPENDiscontinued
AMPICILLIN/AMPICILLIN TRIHYDRATE EQ 250MG BASE · CAPSULE · ORAL
PRINCIPENDiscontinued
AMPICILLIN/AMPICILLIN TRIHYDRATE EQ 500MG BASE · CAPSULE · ORAL

Approval history

1988-03-04OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →